Swiss pharma giant says it's 'too soon' to know whether malaria drug could be coronavirus vaccineCNBC • 03/27/20
U.S. and EU Regulators Reviewing Novartis' Leukemia Drug for Expanded Approval in Multiple SclerosisThe Motley Fool • 02/24/20
Potential Lung Cancer Drug from Incyte and Novartis to Get a Priority Review from FDAThe Motley Fool • 02/11/20
5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher24/7 Wall Street • 02/11/20
Mereo BioPharma Enters into a $5 Million Convertible Equity Financing with Novartis and Announces a Securities Purchase Agreement with Aspire Capital Fund, LLC for up to $28 MillionGlobeNewsWire • 02/10/20
Video: Novartis’s chief digital officer on how the company is becoming un-bossedFast Company • 02/04/20
The FDA and FTC Announce an Effort to Deter Anti-Competitive Practices Among DrugmakersThe Motley Fool • 02/04/20